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Exome Sequencing Identifies
Genetic Variants Associated with
Circulating Lipid Levels in Mexican
Americans: The Insulin Resistance
Atherosclerosis Family Study
(IRASFS)
Chuan Gao1,2, Keri L. Tabb2,3, Latchezar M. Dimitrov2, Kent D. Taylor5, Nan Wang6,
Xiuqing Guo5, Jirong Long7, Jerome I. Rotter5, Richard M. Watanabe6, Joanne E. Curran8,
John Blangero8, Carl D. Langefeld4, Donald W. Bowden2,3 & Nicholette D. Palmer 2,3
Genome-wide association studies have identified numerous variants associated with lipid levels; yet,
the majority are located in non-coding regions with unclear mechanisms. In the Insulin Resistance
Atherosclerosis Family Study (IRASFS), heritability estimates suggest a strong genetic basis: lowdensity lipoprotein (LDL, h2 = 0.50), high-density lipoprotein (HDL, h2 = 0.57), total cholesterol (TC,
h2 = 0.53), and triglyceride (TG, h2 = 0.42) levels. Exome sequencing of 1,205 Mexican Americans (90
pedigrees) from the IRASFS identified 548,889 variants and association and linkage analyses with lipid
levels were performed. One genome-wide significant signal was detected in APOA5 with TG (rs651821,
PTG = 3.67 × 10−10, LODTG = 2.36, MAF = 14.2%). In addition, two correlated SNPs (r2 = 1.0) rs189547099
(PTG = 6.31 × 10−08, LODTG = 3.13, MAF = 0.50%) and chr4:157997598 (PTG = 6.31 × 10−08, LODTG = 3.13,
MAF = 0.50%) reached exome-wide significance (P < 9.11 × 10−08). rs189547099 is an intronic SNP in
FNIP2 and SNP chr4:157997598 is intronic in GLRB. Linkage analysis revealed 46 SNPs with a LOD > 3
with the strongest signal at rs1141070 (LODLDL = 4.30, PLDL = 0.33, MAF = 21.6%) in DFFB. A total
of 53 nominally associated variants (P < 5.00 × 10−05, MAF ≥ 1.0%) were selected for replication in
six Mexican-American cohorts (N = 3,280). The strongest signal observed was a synonymous variant
(rs1160983, PLDL = 4.44 × 10−17, MAF = 2.7%) in TOMM40. Beyond primary findings, previously reported
lipid loci were fine-mapped using exome sequencing in IRASFS. These results support that exome
sequencing complements and extends insights into the genetics of lipid levels.
Cardiovascular disease (CVD) is the leading cause of death worldwide1. In the United States, CVD accounts
for more deaths than any other major cause and, on average, 2,200 Americans die of CVD each day2. While the
exact mechanism of disease remains unclear, lipid concentrations are well-accepted as a major risk factor as well
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Female (%)

58.5

41.1

100.0

27.5

41.1

42.6

38.9

Age (years)b

42.7 ± 14.5

54.1 ± 8.2

34.9 ± 6.4

34.7 ± 7.9

39.3 ± 15.1

34.7 ± 9.1

38.1 ± 14.9

Body Mass Index (BMI; kg/m2)

28.9 ± 6.2

28.2 ± 5.1

30.8 ± 5.6

29.6 ± 6.1

29.3 ± 5.7

29.0 ± 5.2

29.1 ± 6.3

High-density Lipoprotein (HDL; mg/dl)

43.61 ± 12.86

43.18 ± 14.63

37.39 ± 9.52

46.89 ± 11.08

48.13 ± 13.24

46.14 ± 12.12

47.5 ± 11.7

Low-density Lipoprotein (LDL; mg/dl)

109.41 ± 31.04 140.04 ± 36.75 109.01 ± 27.30 102.80 ± 28.65 106.03 ± 31.38 108.23 ± 31.3

106.63 ± 32.01

Total Cholesterol (TC; mg/dl)

178.06 ± 37.45 210.90 ± 43.74 173.15 ± 32.59 172.52 ± 33.25 179.01 ± 35.41 180.53 ± 36.43

181.47 ± 39.23

Triglycerides (TG; mg/dl)

124.80 ± 84.00 157.24 ± 99.21 133.79 ± 78.91 114.12 ± 90.27 124.23 ± 78.96 137.25 ± 102.82 145.19 ± 166

Table 1. Demographic information of the study individuals.
as clinical indicators for CVD. Genetic studies have suggested a strong heritability for circulating lipid levels,
i.e. total cholesterol (TC), LDL cholesterol (LDL), HDL cholesterol (HDL), and triglycerides (TG). Based on a
European twin-pairs study, it is estimated that circulating lipid heritability ranges from 0.58 to 0.66 (h2HDL = 0.61,
h2LDL = 0.59, h2TC = 0.58, h2TG = 0.66)3.
Given the public health relevance as well as the strong genetic component, numerous genome-wide association studies (GWAS) have been performed to investigate the genetic architecture of circulating lipid levels.
The most recent Global Lipid Genetics Consortium (GLGC) analyzed 188,577 individuals from four ethnicities (Europeans, East Asians, South Asians, and Africans) and identified 157 loci associated with plasma lipid
traits4. While well-powered, these efforts have largely overlooked the fastest growing US minority population,
Hispanic Americans. Compared to non-Hispanic whites, Hispanics suffer an even higher risk for CVD, i.e. 32.1%
versus 23.8%5,6. Until now, the largest lipid GWAS in Hispanics was performed by Below et al. in 2015 with
4,383 Mexican ancestry individuals. However, all genome-wide significant regions identified in the Mexican
meta-analysis were previously identified4,7–9.
GWAS were designed with a focus on common variants, partly supported by the “common disease, common
variant” hypothesis10. However, despite the large number of genetic signals identified by GWAS, over 80% fall outside of protein coding regions, which complicates causal inference10. Among genes with evidence of association,
only a small proportion of the variance is explained, providing limited information for disease risk prediction4,11.
Sequencing of the exome, rather than the entire human genome, has been shown to be an efficient strategy to
search for novel variants with a clear biological mechanism12. Previous exome sequencing studies have identified
multiple rare variants associated with CVD in non-Hispanic populations13,14.
To search for functional coding variants regulating circulating lipid levels in a Mexican-ancestry population,
whole exome sequencing was performed in 1,205 Mexican Americans from the Insulin Resistance Atherosclerosis
Family Study (IRASFS). Association and family-based linkage analyses were performed for 548,889 variants. We
hypothesized that a family cohort would have increased power to detect rare variants due to their transmission in
multigenerational pedigrees. With the complimentary approaches of linkage and association, exome sequencing
has the potential to identify ethnic-specific variants regulating lipid levels.

Results

A total of 1,205 individuals were included in association and linkage analyses. Characteristics of the study individuals are shown in Table 1. Overall, individuals were predominantly female (59%) and were overweight with
an average BMI of 28.9 kg/m2. Since the recruitment was based on family size rather than diagnosis, e.g. CVD
was not required for participation, the participants were metabolically normal, with an average HDL (43.61 mg/
dl), LDL (109.41 mg/dl), TC (178.06 mg/dl), and TG (124.80 mg/dl) within desirable or near-desirable ranges15.
According to the National Cholesterol Education Program (NCEP)15, 183 individuals (15%) within the study
had undesirable high TG levels (TG > 150 mg/dl), 121 (10%) individuals had an LDL level greater than 160 mg/
dl, 521 (43%) individuals had an HDL level less than 40 mg/dl, and 290 (24%) individuals had a TC level greater
than 200 mg/dl.
Heritability analysis in IRASFS suggested a strong genetic component for lipid levels. HDL had the
strongest heritability (h2HDL = 0.57) with 17.2% of the variance explained by covariates (age, sex, center,
BMI; P = 5.87 × 10−26), the heritability of TC was 0.53 with 10.3% of the variance explained by covariates (P = 3.12 × 10−23), the heritability of LDL was 0.50 with 7.3% of the variance explained by covariates
(P = 1.22 × 10−21), and TG had the lowest heritability (h2TG = 0.42) with 15.9% of the variance explained by covariates (P = 5.37 × 10−14) (Table S1).
From exome sequencing data, a total of 548,889 variants were successfully analyzed for association and linkage. Among them, 30.0% (164,591) were extremely rare variants with only one or two observations and 82.5%
(452,807) were low frequency variants as defined by a MAF < 5% (Figure S1); 6.8% (N = 37,157) of the variants
were insertions/deletions; 33.1% (N = 182,020) and 15% (N = 83,874) of the variants marked a non-synonymous
and synonymous amino acid change in coding genes, respectively.
Association and linkage results are shown in Figs 1–4. The strongest evidence of association attaining
genome-wide significance (P < 5.00 × 10−08) was observed at the apolipoprotein A-V gene (APOA5) on chromosome 11 with two highly correlated SNPs (r2 = 0.92) rs651821 (P = 3.67 × 10−10, LOD = 2.36, MAF = 14%)
and rs2072560 (P = 5.14 × 10−10, LOD = 2.05, MAF = 13%) and TG (Fig. 4; Table 2). Conditional analysis on one
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Figure 1. Opposed plots for association and linkage analysis of HDL. Association results are plotted on the
positive y-axis. The line at –log10(PVAL) = 7.30 represents genome-wide significance (P = 5.00 × 10−08). The
linkage results are plotted on the negative y-axis. The line at LOD = 3 represents a significant linkage signal.

Figure 2. Opposed plots for association and linkage analysis of LDL. Association results are plotted on the
positive y-axis. The line at –log10(PVAL) = 7.30 represents genome-wide significance (P = 5.00 × 10−08). The
linkage results are plotted on the negative y-axis. The line at LOD = 3 represents a significant linkage signal.

variant was able to abolish the signal limiting the ability to statistically implicate a functional variant. In addition,
both SNPs were also nominally associated with HDL (Prs651821 = 2.63 × 10−3; Prs2072560 = 9.42 × 10−3), while no
signal was detected for LDL (P > 0.90) or TC (P > 0.18). On average, individuals had 23% more TG for each risk
allele carried at rs651821 (TT: 117.59 mg/dl, TC: 142.62 mg/dl, CC: 174.41 mg/dl). Nominally associated and
linked signals are provided in Table S2.
Additional evidence of association which attained exome-wide significance (P < 9.11 × 10−08; based on a
conservative Bonferroni correction for 548,889 variants) included two correlated SNPs (r2 = 1.0) on chromosome 4: rs189547099 (PTG = 6.31 × 10−08, LODTG = 3.13, MAF = 0.5%) and chr4:157997598 (PTG = 6.31 × 10−08,
LODTG = 3.13, MAF = 0.5%) (Table 2). Notably, these variants were both significantly associated and linked
with TG. SNP rs189547099 is an intronic SNP located in the folliculin interacting protein 2 gene (FNIP2) and
the chromosome 4 open reading frame 45 (C4orf25). SNP chr4:157997598 is located 1,817 kb upstream of SNP
rs189547099 in the first intron of the glycine receptor beta gene (GLRB). On average, risk allele (T) heterozygous
carriers for chr4:157997598 had 2.9 times TG compared to non-carriers (CC: 124 mg/dl vs. TC: 358 mg/dl). No
risk allele homozygotes were found. Burden testing failed to identify additional genes significantly associated with
lipid phenotypes after correction for the number of test performed, i.e. P < 7.23 × 10−06, 0.05/139,173; Table S3.
Two-point linkage analysis was performed for 548,889 variants. Of these, two SNPs had a LOD score greater
than 4 (Table 2), 46 SNPs had a LOD score greater than 3 (Table S4). Among these, 14 variants were significantly
linked (LOD > 3) with TC, 13 variants were significantly linked with HDL, 13 variants were significantly linked
with TG, and 8 variants were significantly linked with LDL with two variants overlapping between TC and LDL.
The strongest linkage signal was observed at SNP rs1141070 (LODLDL = 4.30 LODTC = 3.93, MAF = 22%) with
LDL and TC levels. rs1141070 is located in exon 5 of the DNA fragmentation factor gene (DFFB) on chromosome
1 and marks a synonymous amino acid substitution. In addition, SNP rs11648905 (LODLDL = 4.28, LODTC = 3.77,
MAF = 41%) was strongly linked with LDL and TC levels. This variant is an intronic SNP located between exon
7 and 8 of the transmembrane protein 8 A gene (TMEM8A). No significant association signals were observed for
the two linked signals: rs1141070, PLDL = 0.33, PTC = 0.74; rs11648905, PLDL = 0.78, PTC = 0.84 (Table 2).

Meta-analysis. Meta-analysis with six additional independent cohorts was computed for the 53 selected
SNPs. Overall, six variants reached genome-wide significance after meta-analysis (Table 3). The strongest signal was observed at rs1160983 (PLDL = 4.44 × 10−17, MAF = 2.7%) with LDL. rs1160983 is a synonymous coding variant in the translocase of outer mitochondrial membrane 40 gene (TOMM40). The two APOA5 variants,
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SNP

Chr:Pos
(hg19)

Gene

Annotation

Allelesa

RAFb

PHDL

LODHDL

PLDL

LOGLDL

PTC

LODTC

PTG

LODTG

rs1141070

1:3786189

DFFB

coding-synon

A/G

0.22

0.98

0.01

0.33

4.30

0.74

3.93

0.87

0.27

chr4:157997598

4:157997598

GLRB

intron

T/C

0.0050

2.88E-04

1.87

0.71

0

0.24

0

6.31E-08

3.13

rs189547099

4:159814881

C4orf45

intron

C/G

0.0050

2.88E-04

1.87

0.71

0

0.24

0

6.31E-08

3.13

rs2072560

11:116661826

APOA5

intron

T/C

0.13

2.03E-03

0.32

0.87

0

0.014

0.010

5.14E-10

2.06

rs651821

11:116662579

APOA5

intron

C/T

0.14

8.93E-04

0.30

0.99

0

0.018

0

3.67E-10

2.36

rs11648905

16:425298

TMEM8A

intron

T/G

0.41

0.74

0

0.78

4.28

0.84

3.77

0.18

0.82

Table 2. Top association (P < 9.11 × 10−08) and linkage signals (LOD > 4). aReference (minor)/Other allele;
b
Reference allele frequency based on the entire population.

IRASFS

Meta-analysis

SNP

Chr:Pos (hg19)

RAFa

Trait

Gene

Annotation

N

P

N

P

rs2072560

11:116661826

0.13

TG

APOA5

intron

1205

5.14E-10

4241

5.67E-16

rs651821

11:116662579

0.14

TG

APOA5

intron

1205

3.67E-10

4241

2.66E-15

rs2070665

11:116707684

0.17

TG

APOA1

intron

1205

4.10E-05

4241

7.03E-09

rs1532625

16:57005301

0.38

HDL

CETP

intron

1205

2.46E-07

4235

7.72E-14

rs11076176

16:57007446

0.28

HDL

CETP

intron

1205

3.87E-06

4235

2.15E-08

rs1160983

19:45397229

0.027

LDL

TOMM40

synonymous

1205

8.61E-06

4177

4.44E-17

Table 3. Top association signals (P < 5 × 10−8) from meta-analysis. aReference allele frequency based on the
IRASFS cohort.

which attained genome-wide significance in IRASFS, were also successfully replicated (meta-analysis p-values:
rs2072560, PTG = 5.67 × 10−16; rs651821, PTG = 2.66 × 10−15) with a consistent direction of effect across all
cohorts. In addition, strong meta-analysis signals were detected for APOA1 (rs2070665, PTG = 7.03 × 10−09) and
CETP (rs1532625, PHDL = 7.72 × 10−14, rs11076176, PHDL = 2.15 × 10−08) with TG and HDL, respectively. SNP
rs72685601 was selected as the proxy SNP (r2 = 0.59) for the two variants that reached exome-wide significance
(chr4:157997598, rs189547099). It was nominally associated with TG (PTG = 3.69 × 10−03) with consistent direction of effect across six of the seven cohorts. A complete list of meta-analysis results can be found in Table S5.

Previously identified lipid loci. Fine-mapping of the previously identified 157 loci +/−100 kb resulted in
a total of 14,232 exome sequencing variants which were analyzed for association and linkage in IRASFS. In addition, conditional analyses based on the locus-specific GLGC index SNP were performed (Table S6). For association, 1,231 of the variants were identified with a P-value less than 0.05 with at least one of the reported lipid traits.
Among the 1,231 significant variants, 646 remained to be significant (P < 0.05) after conditional analysis based
on the locus-specific index SNP. The strongest association signal was observed at rs651821 (PTG = 3.67 × 10−10,
LODTG = 2.36) in APOA5. After conditioning on SNP rs964184, it remained nominally associated and linked
with TG (PTG|rs964184 = 1.76 × 10−04, LODTG|rs964184 = 0.99). In addition, SNP rs1532625 also survived the stringent
Bonferroni correction (P < 3.51 × 10−06 for 14,232 variants): PHDL = 2.46 × 10−07, LODHDL = 1.42. This SNP is an
intronic variant located in the cholesteryl ester transfer protein gene (CETP). However, conditional analysis with
the index SNP rs3764261 totally abolished the signal (PHDL|rs3764261 = 0.61, LODHDL|rs3764261 = 0.02). For linkage
analysis, 14 and 127 SNPs reached a LOD score greater than two and one, respectively, for at least one reported
lipid trait. Among them, one (rs1134760, LODHDL|rs16942887 = 2.46) and 28 (LOD > 1) remained to be linked after
conditional analysis, respectively.

Discussion

An individual’s lipid profile represents a well-accepted major risk factor and clinical indicator of CVD. In this
study, heritability estimates for four lipid phenotypes were reported in Mexican Americans from IRASFS and
demonstrated a strong genetic component. Subsequently, exome-wide association analysis was performed using
exome sequencing data derived from 1,205 Mexican Americans from IRASFS. Multiple significant association
signals were identified and top signals were evaluated in six additional independent cohorts (n = 3,280). As a
complementary approach to association, linkage analysis was performed to identify rare variant signals. In addition, 157 previously identified lipid loci were fine-mapped using exome sequencing data in IRASFS.
Strong association and suggestive linkage signals were observed with two SNPs in APOA5: rs651821
(PTG = 3.67 × 10−10, LODTG = 2.36, MAF = 14%) and rs2072560 (PTG = 5.14 × 10−10, LODTG = 2.05, MAF = 13%).
APOA5 encodes an apoliporotein that plays an important role in regulating plasma triglyceride levels, which is a
strong risk factor for CVD16. This gene is located within the apolipoprotein gene cluster on chromosome 11q23.3,
which contains multiple lipid-related genes including APOA1, APOA3, APOA4, APOA5, and PCSK7. Multiple
strong association signals have been identified in the region with HDL, TG, and TC4,9,17. In 2015, Do et al.14
described a large exome sequencing study in 9,793 European and African Americans and identified strong associations between APOA5 functional variants and myocardial infraction (MI). A recent Hispanic GWAS of lipid
SCIENTIFIC RePorts | (2018) 8:5603 | DOI:10.1038/s41598-018-23727-2
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Figure 3. Opposed plots for association and linkage analysis of TC. Association results are plotted on the
positive y-axis. The line at –log10(PVAL) = 7.30 represents genome-wide significance (P = 5.00 × 10−08). The
linkage results are plotted on the negative y-axis. The line at LOD = 3 represents a significant linkage signal.

Figure 4. Opposed plots for association and linkage analysis of TG. Association results are plotted on the
positive y-axis. The line at –log10(PVAL) = 7.30 represents genome-wide significance (P = 5.00 × 10−08). The
linkage results are plotted on the negative y-axis. The line at LOD = 3 represents a significant linkage signal.

phenotypes identified SNP rs964184, 359 bases downstream of zinc finger protein 259 (ZNF259) and 11 kb downstream of APOA5, as significantly associated with TG7. In addition, Parra et al. presented robust association for
rs964184 and no comparable signals were identified in the 5’ UTR for APOA518. In IRASFS, SNP rs964184 was
also associated with TG (P = 4.79 × 10−07). However, including SNP rs964184 as a covariant failed to completely
abolish the genetic signal of rs651821 (Pbefore = 3.67 × 10−10, Pafter = 1.76 × 10−−04), suggesting that the two signals
were likely independent (r2 = 0.37) (Figure S2).
In IRASFS, two common variants (rs651821, rs2072560) within APOA5 were identified with strong association signals with TG in a Mexican-American family cohort. While SNP rs651821 and rs2072560 have been
previously identified to be strongly associated with TG in multiple ethnicities (Europeans, East Asians, and
North Africans)19–23, this is the first reported evidence in a Mexican-ancestry population. SNP rs651821 is a
5′-UTR variant that is three bases upstream of the coding exon. Worth mentioning, rs651821 is also located in
the binding site of transcription factor POLR2A as suggested in HepG2 cells by ENCODE24. Previous expression quantitative trait loci (eQTL) studies revealed associations between rs651821 and transgelin (TAGLN) gene
expression levels25 yet no APOA5 expression regulation effect was found. SNP rs2072560 is located intronically
between exons 3 and 4 of APOA5. Interestingly, rs2072560 is also a missense variant of an alternative transcript
of APOA5 (NM_001166598) which contains two exons. This variant marks a glutamic acid to glycine amino acid
change (E66G) in exon 2 (Figure S5). To further explore the potential function of the alternative transcript, four
ENCODE primary hepatocyte RNA sequencing experiments were analyzed and plotted using the UCSC genome
browser24,26. However, no RNA sequencing evidence was found to support existence or function of the alternative
transcript (Figure S5). Taken together, strong association, linkage, and replication signals were identified for the
two APOA5 SNPs with TG in Mexican Americans. While not enough biological evidence was found to support
their causality, the results refined the scope of the APOA5 association signals and provided information for future
efforts to locate the causal variant in the region.
While not attaining strict genome-wide significance, two correlated SNPs (r 2 = 1.0) rs189547099
(PTG = 6.31 × 10−08, LODTG = 3.13, MAF = 0.5%) and chr4:157997598 (PTG = 6.31 × 10−08, LODTG = 3.13,
MAF = 0.5%) were detected with exome-wide significance. These are two rare SNPs with 12 heterozygous and
no homozygous carriers. SNP rs189547099 is an intronic variant for both the chromosome 4 open reading frame
45 gene (C4orf45) and folliculin interacting protein 2 gene (FNIP2). C4orf45 is an uncharacterized gene with
unknown biological function. GTEx27 has detected that C4orf45 is strongly expressed in testis, yet there was
almost no expression in other tissues. FNIP2 is a tumor suppressor gene that has been shown to be involved
SCIENTIFIC RePorts | (2018) 8:5603 | DOI:10.1038/s41598-018-23727-2
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in regulating the apoptosis signaling pathway in tumors and is responsible for cellular metabolism and nutrient sensing28,29. SNP chr4:157997598 is an intronic variant in the glycine receptor beta gene (GLRB). This gene
encodes the beta subunit of the glycine receptor and has been shown to function as a neurotransmitter-gated ion
channel. Mutations in this gene have been shown to cause startle disease30,31. Interestingly, SNP chr4:157997598 is
located in a CpG island and modifies the binding consensus sequence for a transcription factor zinc finger protein
263 (ZNF263) (Figure S6). Although no biological mechanism was found between GLRB and lipid metabolism,
it is possible that SNP chr4:157997598 regulates TG levels through ZNF263.
Among the 53 variants identified for replication, synonymous SNP rs1160983 in exon 5 of the translocase of
outer mitochondrial membrane 40 gene (TOMM40) exhibited the strongest association signal after replication
and meta-analysis with six independent cohorts (PLDL = 4.44 × 10−17, MAF = 2.7%). Before meta-analysis, this
variant was nominally associated in IRASFS (PLDL = 8.61 × 10−06). TOMM40 has been shown to be the forming
subunit of the translocase of the mitochondrial outer membrane complex and is essential for the import of protein precursors into mitochondria32. Genetic studies have identified two adjacent genes (APOE and TOMM40)
in this region to be highly associated with circulating lipid levels4,33. After reviewing previously identified APOE
variants, SNP rs7412 has the highest LD with rs1160983 (r2 = 0.49, D′ = 0.94). In IRASFS, rs7412 was nominally
associated with LDL (PLDL = 6.61 × 10−06). Interestingly, after adjusting for the APOE variant (rs7412), rs1160983
remained nominally significant (P = 9.10 × 10−03) with LDL. This suggests that the known APOE signals do not
fully explain the rs1160983 signal in TOMM40. It is possible that TOMM40 may directly contribute to the regulation of LDL levels or SNP rs1160983 may influence APOE expression.
An interesting observation from this study is the lack of overlap between the majority of linkage and association signals, even with exome sequencing data. One explanation is that association and linkage capture different
mechanisms of phenotypic contributions. Association analysis detects signals that statistically associate with phenotypic variability either directly or through linkage disequilibrium (LD) and thus targets more proximal effects.
Linkage detects the co-segregation of an allele with the phenotype in families and therefore can detect long-range
effects due to limited recombination events across successive generations. Therefore, each approach has its advantages and limitations. For example, association analysis has gained much success in common variant analysis
while often suffering from reduced power to detect rare variants, e.g. statistical power is largely affected by inadequate sample size and limited LD with proximal common variants. In contrast, linkage analysis performance is
largely dependent on family structures as well as the number of segregation events, e.g. when family structures are
incomplete or allele segregation information is incomplete (only two generations or the parental generation allele
information is missing), linkage analysis performance is largely dampened. On the other hand, rare variants (in
populations) that are missed by association can be relatively common in a given family with segregation across
multiple generations. In this scenario, linkage has increased power over association. Taken together, both association and linkage analysis are valuable approaches for analyzing sequencing data in genetic studies, providing
potentially independent information.
Despite multiple strong signals identified, study limitations exist. First, the modest sample size in IRASFS
(n = 1,205) limits the power for the association analysis of rare variants, especially given the fact that 82% of the
variants analyzed had a MAF < 5%. As a complementary approach, linkage analysis in 90 pedigrees was performed and identified signals that were likely missed by association. Unfortunately, linkage analysis was unavailable in the replication cohorts, and therefore meta-analysis of linkage signals was not performed. Dyslipidemia was
not required for participation in IRASFS, thus the majority of individuals were metabolically normal, potentially
providing limited enrichment of genetic risk alleles. Third, exome sequencing was not available in replication
cohorts, and therefore replication was limited to GWAS imputed or proxy variants only. This approach modestly
limited the number of SNPs for replication. Also, while all cohorts were of Mexican ancestry, different ascertainment criteria were used. For example, BetaGene recruited participants at high risk of gestational diabetes while
HTN-IR recruited participants at high risk of hypertension. This differs from IRASFS which is a population-based
study recruited for large family size.
In summary, exome-wide association and linkage analyses were performed using exome sequencing data
in 1,205 Mexican Americans from IRASFS. Multiple signals were detected with circulating lipid levels and top
signals were analyzed in six additional independent cohorts for replication. Our results suggested multiple lipid
genetic signals in APOA5, TOMM40, and GLRB/C4orf45, fine-mapped known lipid genes with exome sequencing data in IRASFS, and explored a combined approach of association and linkage analyzing sequencing data.
These results confirm that exome sequencing is a powerful tool to screen for functional genetic variants in the
population.

Methods

Insulin Resistance Atherosclerosis Family Study (IRASFS).

The study design, recruitment, and phenotyping for the IRASFS has been previously described34. In brief, the IRASFS was designed to investigate the
genetic and environmental basis of insulin resistance and adiposity. Mexican Americans included in this cohort
(n = 1,205 individuals, 90 pedigrees) were recruited from clinical centers in San Antonio, TX and San Luis Valley,
CO. Recruitment was based on reported family size and not on health status. Phenotype acquisition and variable calculations have been previously described34,35. In brief, TC, TG, and HDL were measured from fasting
plasma with standards and LDL was calculated using the Friedewald formula. The study protocol was approved
by the Institutional Review Board of each participating clinical and analysis site and all participants provided
their written informed consent. All methods in this study were carried out in accordance with the principles of
the Declaration of Helsinki.

Exome Sequencing.

Exome sequencing was performed at Texas Biomedical Research Institute using
the Illumina Nextera Exome Enrichment System in conjunction with the Illumina HiSeq 2500 sequencer. All
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sequence reads passed through the Illumina Data Analysis Pipeline, and those from samples passing QC criteria
were mapped to the human genome reference sequence (hg19). A detailed description of the sequencing platform
and analysis pipeline has been published36. Of note, multi-sample recalibration was performed prior to variant
calling. The datasets generated and/or analyzed during the current study are available from the corresponding
author on reasonable request.

Statistical Analysis. To ensure normality, high density lipoprotein (HDL), total cholesterol (TC), and triglycerides (TG) were natural log-transformed; low density lipoprotein (LDL) was square root-transformed. While
lipid medications were carefully evaluated, the majority of the participants in IRASFS were metabolically healthy
with a lipid medication rate of 3.9%. Therefore, only a single regression model was performed without accounting for lipid medication status. Heritability of lipid levels was estimated using Sequential Oligogenic Linkage
Analysis Routines (SOLAR)37 adjusting for age, sex, body mass index (BMI), and recruitment center. Variants
with Mendelian inconsistencies were removed (n = 4,024), resulting in a final number of 548,889 variants38.
Each variant was coded to an additive model based on the minor allele (reference allele). Genetic models of
association were calculated adjusting for age, sex, BMI, recruitment center, and admixture estimates. Admixture
estimates were calculated as described previously39 using maximum likelihood estimation of individual ancestries as implemented in ADMIXTURE40. Tests of association between individual variants and quantitative traits
were computed using the Wald test from the variance component model implemented in SOLAR. Burden tests
were computed using famSKAT41. Gene units were defined using the UCSC gene definition file from NCBI
genome build 37 (hg19) whereby each alternatively spliced transcript is included for a total of 39,173 genes. For
family-based linkage analysis, variant-specific identity-by-descent (IBD) probabilities were computed using the
Monte Carlo method implemented in SOLAR42. Two-point linkage was performed using the variance components method implemented in SOLAR, with adjustment of age, gender, BMI, and recruitment center42. Variant
annotation was performed using ANNOVAR43.
Replication and Meta-analysis. Six cohorts participating in the Genetics Underlying Diabetes
in Hispanics (GUARDIAN) Consortium 44 provided in silico replication data: the Insulin Resistance
Atherosclerosis Study (IRAS45), BetaGene46–49, the Troglitazone in Prevention of Diabetes Study (TRIPOD50,51),
the Hypertension-Insulin Resistance Family Study (HTN-IR52,53), the Mexican-American Coronary Artery
Disease Study (MACAD54–56) and the NIDDM-Atherosclerosis Study (NIDDM-Athero57). All study protocols
were approved by the local institutional review committees and all participants gave their informed consent.
GWAS genotyping was supported through the GUARDIAN Consortium44 using the Illumina OmniExpress
array (Illumina Inc.; San Diego, CA, USA) and imputation was performed centrally using IMPUTE258 and
the 1000 Genomes phase l integrated reference panel (March 2012). Variants included in analysis had confidence scores > 0.90 and information scores > 0.50. A detailed description of quality control has been described
previously39.
A total of 56 nominally associated SNPs (P < 5.00 × 10−05) with minor allele frequency (MAF) ≥ 1.0% as
well as two rare SNPs that reached exome-wide significance (P < 9.11 × 10−08, MAF < 1.0%) were selected for
replication in the GUARDIAN Consortium. Meta-analysis was performed among IRASFS (nmax = 1,205), IRAS
(nmax = 181), BetaGene (nmax = 1,218), TRIPOD (nmax = 125), HTN-IR (nmax = 763), MACAD (nmax = 749), and
NIDDM-Athero (nmax = 244) using the 1000 Genomes imputation dataset. Overall, 49 SNPs were directly tagged
in replication cohorts and four SNPs were tagged by a proxy SNP (r2 > 0.6). However, no available proxies were
found for the remaining five SNPs, which were excluded, resulting in a total of 53 SNPs in the meta-analysis. The
meta-analysis was computed using METAL (http://csg.sph.umich.edu/abecasis/metal). Considering the differential study designs, a weighted meta-analysis of the p-values and samples sizes accounting for direction of effect
was performed.
Previously identified signals. Previously identified lipid loci (N = 157) from the recent GLGC4 were
extracted and all exome sequencing variants within ± 100 kb of the reported index SNPs were selected for
fine-mapping. Conditional association and linkage analyses were performed with the GLGC index SNP as an
adjusting covariate.
ENCODE RNA sequencing data.

Four human primary hepatocytes RNA sequencing results were plotted
using the UCSC genome browser24,26. The four liver biopsy samples included were derived from four European
individuals: GSM2072386 (20-week female), GSM2072387 (22-week male), GSM2072372 (32-year male), and
GSM2072373 (6-year female).
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